Detalhe da pesquisa
1.
CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes.
Cardiovasc Diabetol;
23(1): 104, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38504284
2.
STING1 deficiency ameliorates immune-mediated crescentic glomerulonephritis in mice.
J Pathol;
261(3): 309-322, 2023 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37650295
3.
Targeting inflammation to treat diabetic kidney disease: the road to 2030.
Kidney Int;
103(2): 282-296, 2023 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36470394
4.
Atherosclerotic renovascular disease: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA) and the Working Group Hypertension and the Kidney of the European Society of Hypertension (ESH).
Nephrol Dial Transplant;
38(12): 2835-2850, 2023 Nov 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37202218
5.
SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA.
Nephrol Dial Transplant;
38(11): 2444-2455, 2023 Oct 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37230946
6.
Zilebesiran for Hypertension.
N Engl J Med;
389(15): 1438, 2023 Oct 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37819962
7.
Epigenetic Modifiers as Potential Therapeutic Targets in Diabetic Kidney Disease.
Int J Mol Sci;
21(11)2020 Jun 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32526941
8.
Advances in understanding the role of angiotensin-regulated proteins in kidney diseases.
Expert Rev Proteomics;
16(1): 77-92, 2019 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30412432
9.
First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists.
Ann Intern Med;
176(4): eL230005, 2023 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37068289
10.
Albumin downregulates Klotho in tubular cells.
Nephrol Dial Transplant;
33(10): 1712-1722, 2018 10 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29425318
11.
MXRA5 is a TGF-ß1-regulated human protein with anti-inflammatory and anti-fibrotic properties.
J Cell Mol Med;
21(1): 154-164, 2017 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27599751
12.
PCSK9 in diabetic kidney disease.
Eur J Clin Invest;
46(9): 779-86, 2016 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27438893
13.
Circulating fibroblast growth factor-23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease.
Diabetes Metab Res Rev;
32(7): 685-693, 2016 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26888181
14.
Circulating CXCL16 in Diabetic Kidney Disease.
Kidney Blood Press Res;
41(5): 663-671, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27665581
15.
SGLT2i and postglomerular vasodilation.
Kidney Int;
97(4): 805-806, 2020 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32200864
16.
Fn14 in podocytes and proteinuric kidney disease.
Biochim Biophys Acta;
1832(12): 2232-43, 2013 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23999007
17.
Identification of a urine metabolomic signature in patients with advanced-stage chronic kidney disease.
Kidney Int;
85(1): 103-11, 2014 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24048377
18.
Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy.
Nephrol Dial Transplant;
29(8): 1563-70, 2014 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24589724
19.
Gender-specific risk factors and outcomes of hyperkalemia in CKD patients: smoking as a driver of hyperkalemia in men.
Clin Kidney J;
17(1): sfad212, 2024 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38186899
20.
Sex disparities in mortality and cardiovascular outcomes in chronic kidney disease.
Clin Kidney J;
17(3): sfae044, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38638550